Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cobalamin and osteoblast-specific proteins.

R Carmel1, K H Lau, D J Baylink

  • 1Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.

The New England Journal of Medicine
|July 14, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local administration of AAV-DJ pseudoserotype expressing COX2 provided early onset of transgene expression and promoted bone fracture healing in mice.

Gene therapy·2015
Same author

Genetic regulation of femoral bone mineral density: complexity of sex effect in chromosome 1 revealed by congenic sublines of mice.

Bone·2007
Same author

Detecting novel bone density and bone size quantitative trait loci using a cross of MRL/MpJ and CAST/EiJ inbred mice.

Calcified tissue international·2007
Same author

Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.

Calcified tissue international·2006
Same author

High osteoblastic activity in C3H/HeJ mice compared to C57BL/6J mice is associated with low apoptosis in C3H/HeJ osteoblasts.

Calcified tissue international·2006
Same author

Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.

Calcified tissue international·2006

Vitamin B12 (cobalamin) deficiency impacts bone health by lowering osteoblast activity and related proteins. Supplementation improved these markers in deficient patients, suggesting a role for vitamin B12 in bone metabolism.

Area of Science:

  • Biochemistry
  • Bone Metabolism
  • Nutritional Science

Background:

  • Vitamin B12 (cobalamin) deficiency is known for hematologic and neurologic effects.
  • Limited information exists regarding other systemic impacts of cobalamin deficiency.
  • Osteoblast function and bone metabolism are critical areas for further investigation.

Purpose of the Study:

  • To investigate the effect of cobalamin on osteoblast-related proteins.
  • To determine if cobalamin deficiency impacts bone metabolism markers.
  • To explore the relationship between cobalamin levels and skeletal alkaline phosphatase.

Main Methods:

  • Measured blood levels of skeletal alkaline phosphatase and osteocalcin in cobalamin-deficient patients and controls.
  • Assessed the correlation between megaloblastic anemia severity and skeletal alkaline phosphatase levels.

Related Experiment Videos

  • Conducted in vitro studies using chicken embryo calvarial cells to assess cobalamin's effect on alkaline phosphatase.

    • Main Results:

    • Cobalamin-deficient patients exhibited significantly lower levels of skeletal alkaline phosphatase and osteocalcin compared to controls.
    • A positive correlation was observed between the degree of megaloblastic anemia and reduced skeletal alkaline phosphatase.
    • Cobalamin therapy led to increased skeletal alkaline phosphatase and osteocalcin levels in deficient patients, with no change in controls.
    • In vitro studies confirmed that alkaline phosphatase content in calvarial cells is cobalamin-dependent.

    Conclusions:

    • Osteoblast activity appears to be dependent on cobalamin.
    • Cobalamin deficiency affects bone metabolism, indicated by altered osteoblast-related protein levels.
    • Further research is needed to ascertain if cobalamin deficiency leads to clinically significant bone disease.